Company performance
Current Price
as of Jan 17, 2025$148.39
P/E Ratio
83.95
Market Cap
$4.27B
Description
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Metrics
Overview
- HQPittsburgh, PA
- SectorHealth Technology
- IndustryBiotechnology
- TickerKRYS
- Price$148.39+2.47%
Trading Information
- Market cap$4.27B
- Float84.55%
- Average Daily Volume (1m)279,348
- Average Daily Volume (3m)267,156
- EPS$1.83
Company
- Revenue$241.52M
- Rev growth (1yr)879.91%
- Net income$27.18M
- Gross margin90.25%
- EBITDA margin43.44%
- EBITDA$36.42M
- EV$4.86B
- EV/Revenue20.13
- P/E83.95
- P/S18.37
- P/B4.82
Documents
SEC Filings
Factset Street Account